ArticleThe Lancet regional health. Southeast Asia2026
India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.
Sarbasree Bhattacharjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.